Beranda › Glioblastoma
Uji klinis Glioblastoma yang merekrut di AS
157 studi untuk Glioblastoma merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX25 studi
- Los Angeles, CA23 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Washington, DC15 studi
- Rochester, MN15 studi
- Chicago, IL15 studi
- Miami, FL14 studi
- Columbus, OH14 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
- St. Louis, MO12 studi
- Atlanta, GA11 studi
- Salt Lake City, UT11 studi
- Philadelphia, PA11 studi
- Baltimore, MD11 studi
- Cleveland, OH11 studi
- Baldwin Park, CA10 studi
- Pittsburgh, PA9 studi
- Birmingham, AL9 studi
- Dallas, TX9 studi
- Nashville, TN9 studi
- Phoenix, AZ8 studi
- Winston-Salem, NC8 studi
- Seattle, WA8 studi
- San Antonio, TX8 studi
- San Diego, CA7 studi
- Edison, NJ7 studi
- Cincinnati, OH6 studi
- Tampa, FL6 studi
- Madison, WI6 studi
- Ann Arbor, MI6 studi
- Lexington, KY5 studi
- Mountain View, CA5 studi
- Queens, NY5 studi
- Omaha, NE5 studi
- Arlington, VA5 studi
- Charlottesville, VA5 studi
Berdasarkan negara bagian
- Alabama9 studi
- Arizona13 studi
- California40 studi
- Colorado14 studi
- Connecticut5 studi
- Distrik Columbia9 studi
- Florida30 studi
- Georgia12 studi
- Illinois16 studi
- Indiana4 studi
- Iowa4 studi
- Kansas3 studi
- Kentucky5 studi
- Maryland16 studi
- Massachusetts29 studi
- Michigan11 studi
- Minnesota19 studi
- Missouri12 studi
- Nebraska5 studi
- New Jersey8 studi
- New York33 studi
- North Carolina26 studi
- Ohio23 studi
- Oklahoma4 studi
- Pennsylvania21 studi
- Rhode Island3 studi
- South Carolina3 studi
- Tennessee10 studi
- Texas33 studi
- Utah11 studi
- Virginia10 studi
- Washington9 studi
- Wisconsin8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06991101Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT03970447GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07301268GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Menerima pesertaFase 1
Usia 21 hingga 70 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06815432The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05303467Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07416188Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07145112A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Menerima pesertaFase 1/2
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04094610Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07195591MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT03896568Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06389591OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
Menerima pesertaFase 2
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06558214Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06814496A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05765812Anti-GD2 ADC M3554 in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06641908VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma
Menerima pesertaFase 2
Usia 18 hingga 98 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07831369REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT04977375ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07089641A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Menerima pesertaFase 1
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05698524Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.